I agree that this site is using cookies. You can find further informations
here
.
X
Login
Merkliste (
0
)
Home
About us
Home About us
Our history
Profile
Press & public relations
Friends
The library in figures
Exhibitions
Projects
Training, internships, careers
Films
Services & Information
Home Services & Information
Lending and interlibrary loans
Returns and renewals
Training and library tours
My Account
Library cards
New to the library?
Download Information
Opening hours
Learning spaces
PC, WLAN, copy, scan and print
Catalogs and collections
Home Catalogs and Collections
Rare books and manuscripts
Digital collections
Subject Areas
Our sites
Home Our sites
Central Library
Law Library (Juridicum)
BB Business and Economics (BB11)
BB Physics and Electrical Engineering
TB Engineering and Social Sciences
TB Economics and Nautical Sciences
TB Music
TB Art & Design
TB Bremerhaven
Contact the library
Home Contact the library
Staff Directory
Open access & publishing
Home Open access & publishing
Reference management: Citavi & RefWorks
Publishing documents
Open Access in Bremen
zur Desktop-Version
Toggle navigation
Merkliste
1 Ergebnisse
1
Association between the efficacy and immune-related adverse..:
Kana Kurokawa
;
Yoichiro Mitsuishi
;
Naoko Shimada
...
https://doi.org/10.1186/s12885-022-10133-1. , 2022
Link:
https://doi.org/10.1186/s12885-022-10133-1
RT Journal T1
Association between the efficacy and immune-related adverse events of pembrolizumab and chemotherapy in non-small cell lung cancer patients: a retrospective study
UL https://suche.suub.uni-bremen.de/peid=base-ftdoajarticles:oai:doaj.org_article:b88f8c49b99047a9aa547157583c9d57&Exemplar=1&LAN=DE A1 Kana Kurokawa A1 Yoichiro Mitsuishi A1 Naoko Shimada A1 Yuta Kawakami A1 Keita Miura A1 Taichi Miyawaki A1 Tetsuhiko Asao A1 Ryo Ko A1 Takehito Shukuya A1 Rina Shibayama A1 Shuko Nojiri A1 Kazuhisa Takahashi PB BMC YR 2022 K1 Non‐small cell lung cancer K1 Immune-checkpoint inhibitors K1 Combination therapy K1 Immune-related adverse events K1 Neoplasms. Tumors. Oncology. Including cancer and carcinogens K1 RC254-282 JF https://doi.org/10.1186/s12885-022-10133-1 LK http://dx.doi.org/https://doi.org/10.1186/s12885-022-10133-1 DO https://doi.org/10.1186/s12885-022-10133-1 SF ELIB - SuUB Bremen
Export
RefWorks (nur Desktop-Version!)
Flow
(Zuerst in
Flow
einloggen, dann importieren)